Literature DB >> 26145099

Estimating the prevalence of mixed-type gonococcal infections in Queensland, Australia.

Ella Trembizki1, Christine Doyle2, Cameron Buckley1, Amy Jennison2, Helen Smith2, John Bates2, Theo Sloots1, Michael Nissen1, Monica M Lahra3, David Whiley1.   

Abstract

UNLABELLED: Background Mixed gonococcal infections within the one anatomical site have been recognised but questions remain over how often they occur. In this study, the aim was to estimate the prevalence of mixed gonococcal infections using novel real-time polymerase chain reaction (PCR) methods that were developed and validated, targeting the gonococcal porB gene.
METHODS: Neisseria gonorrhoeae strains were categorised into three different porB groups, based on sequence data derived from N. gonorrhoeae multi-antigen sequence typing (NG-MAST) analyses of local isolates. Specific PCR methods for each group were then developed and these PCR methods were used to test clinical samples (n=350) that were positive for gonorrhoea as determined by nucleic acid amplification test (NAAT) diagnostic screening.
RESULTS: Initial validation using isolates showed the group PCR methods proved 100% sensitive and 100% specific for their respective porB groups. When applied to the clinical specimens, 298/350 (85%) provided positive results by the group PCR methods. Of these, four specimens showed evidence of mixed infections, supported by subsequent DNA sequencing of the PCR products.
CONCLUSIONS: The data provide further evidence of mixed gonococcal infections at the same anatomical site, but show that such infections may be relatively infrequent (1.3%; 95% confidence interval 0.01-2.6%) in a general screening population.

Entities:  

Year:  2015        PMID: 26145099     DOI: 10.1071/SH15009

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  4 in total

1.  Evidence of Recent Genomic Evolution in Gonococcal Strains With Decreased Susceptibility to Cephalosporins or Azithromycin in the United States, 2014-2016.

Authors:  Jesse C Thomas; Sandra Seby; A Jeanine Abrams; Jack Cartee; Sean Lucking; Eshaw Vidyaprakash; Matthew Schmerer; Cau D Pham; Jaeyoung Hong; Elizabeth Torrone; Sancta St Cyr; William M Shafer; Kyle Bernstein; Ellen N Kersh; Kim M Gernert
Journal:  J Infect Dis       Date:  2019-06-19       Impact factor: 5.226

Review 2.  Strategies for successful designing of immunocontraceptive vaccines and recent updates in vaccine development against sexually transmitted infections - A review.

Authors:  A S Vickram; Kuldeep Dhama; S Thanigaivel; Sandip Chakraborty; K Anbarasu; Nibedita Dey; Rohini Karunakaran
Journal:  Saudi J Biol Sci       Date:  2022-01-07       Impact factor: 4.052

3.  Molecular Antimicrobial Resistance of Neisseria gonorrhoeae in a Moroccan Area.

Authors:  Safae Karim; Chahrazed Bouchikhi; Abdelaziz Banani; Hinde El Fatemi; Tiatou Souho; Sanaa Erraghay; Bahia Bennani
Journal:  Infect Dis Obstet Gynecol       Date:  2018-11-21

4.  Systematic review and survey of Neisseria gonorrhoeae ceftriaxone and azithromycin susceptibility data in the Asia Pacific, 2011 to 2016.

Authors:  C R Robert George; Rodney P Enriquez; Barrie J Gatus; David M Whiley; Ying-Ru Lo; Naoko Ishikawa; Teodora Wi; Monica M Lahra
Journal:  PLoS One       Date:  2019-04-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.